231 related articles for article (PubMed ID: 29580804)
1. Neurometabolite levels in antipsychotic-naïve/free patients with schizophrenia: A systematic review and meta-analysis of
Iwata Y; Nakajima S; Plitman E; Mihashi Y; Caravaggio F; Chung JK; Kim J; Gerretsen P; Mimura M; Remington G; Graff-Guerrero A
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Aug; 86():340-352. PubMed ID: 29580804
[TBL] [Abstract][Full Text] [Related]
2. Treatment effects on neurometabolite levels in schizophrenia: A systematic review and meta-analysis of proton magnetic resonance spectroscopy studies.
Kubota M; Moriguchi S; Takahata K; Nakajima S; Horita N
Schizophr Res; 2020 Aug; 222():122-132. PubMed ID: 32505446
[TBL] [Abstract][Full Text] [Related]
3. Striatal neurometabolite levels in patients with schizophrenia undergoing long-term antipsychotic treatment: A proton magnetic resonance spectroscopy and reliability study.
Plitman E; Chavez S; Nakajima S; Iwata Y; Chung JK; Caravaggio F; Kim J; Alshehri Y; Chakravarty MM; De Luca V; Remington G; Gerretsen P; Graff-Guerrero A
Psychiatry Res Neuroimaging; 2018 Mar; 273():16-24. PubMed ID: 29414127
[TBL] [Abstract][Full Text] [Related]
4. Glutamatergic and Neuronal Dysfunction in Gray and White Matter: A Spectroscopic Imaging Study in a Large Schizophrenia Sample.
Bustillo JR; Jones T; Chen H; Lemke N; Abbott C; Qualls C; Stromberg S; Canive J; Gasparovic C
Schizophr Bull; 2017 May; 43(3):611-619. PubMed ID: 27550776
[TBL] [Abstract][Full Text] [Related]
5. Treatment effects on neurometabolite levels in schizophrenia: A meta-analysis dataset of proton magnetic resonance spectroscopy.
Kubota M; Moriguchi S; Takahata K; Nakajima S; Horita N
Data Brief; 2020 Aug; 31():105862. PubMed ID: 32637482
[TBL] [Abstract][Full Text] [Related]
6. Proton magnetic resonance spectroscopic imaging of gray and white matter in bipolar-I and schizophrenia.
Bustillo JR; Jones T; Qualls C; Chavez L; Lin D; Lenroot RK; Gasparovic C
J Affect Disord; 2019 Mar; 246():745-753. PubMed ID: 30623820
[TBL] [Abstract][Full Text] [Related]
7. Neurometabolite levels in the brains of patients with autism spectrum disorders: A meta-analysis of proton magnetic resonance spectroscopy studies (N = 1501).
Du Y; Chen L; Yan MC; Wang YL; Zhong XL; Xv CX; Li YB; Cheng Y
Mol Psychiatry; 2023 Jul; 28(7):3092-3103. PubMed ID: 37117459
[TBL] [Abstract][Full Text] [Related]
8. Meta-analytic evidence of elevated choline, reduced N-acetylaspartate, and normal creatine in schizophrenia and their moderation by measurement quality, echo time, and medication status.
Yang YS; Smucny J; Zhang H; Maddock RJ
Neuroimage Clin; 2023; 39():103461. PubMed ID: 37406595
[TBL] [Abstract][Full Text] [Related]
9. A comparison of neurometabolites between remitted bipolar disorder and depressed bipolar disorder: A proton magnetic resonance spectroscopy study.
Liu T; Wang Y; Zhong S; Wang B; Liao X; Lai S; Jia Y
J Affect Disord; 2017 Mar; 211():153-161. PubMed ID: 28126615
[TBL] [Abstract][Full Text] [Related]
10. Elevated Myo-Inositol, Choline, and Glutamate Levels in the Associative Striatum of Antipsychotic-Naive Patients With First-Episode Psychosis: A Proton Magnetic Resonance Spectroscopy Study With Implications for Glial Dysfunction.
Plitman E; de la Fuente-Sandoval C; Reyes-Madrigal F; Chavez S; Gómez-Cruz G; León-Ortiz P; Graff-Guerrero A
Schizophr Bull; 2016 Mar; 42(2):415-24. PubMed ID: 26320195
[TBL] [Abstract][Full Text] [Related]
11. Neurometabolites in schizophrenia and bipolar disorder - a systematic review and meta-analysis.
Kraguljac NV; Reid M; White D; Jones R; den Hollander J; Lowman D; Lahti AC
Psychiatry Res; 2012; 203(2-3):111-25. PubMed ID: 22981426
[TBL] [Abstract][Full Text] [Related]
12. Proton magnetic resonance spectroscopy of the human brain in schizophrenia.
Deicken RF; Johnson C; Pegues M
Rev Neurosci; 2000; 11(2-3):147-58. PubMed ID: 10718151
[TBL] [Abstract][Full Text] [Related]
13. Intralipid/Heparin Infusion Alters Brain Metabolites Assessed With 1H-MRS Spectroscopy in Young Healthy Men.
Karczewska-Kupczewska M; Nikolajuk A; Filarski R; Majewski R; Tarasów E
J Clin Endocrinol Metab; 2018 Jul; 103(7):2563-2570. PubMed ID: 29860500
[TBL] [Abstract][Full Text] [Related]
14. Proton magnetic resonance spectroscopy in subjects with high genetic risk of schizophrenia: investigation of anterior cingulate, dorsolateral prefrontal cortex and thalamus.
Yoo SY; Yeon S; Choi CH; Kang DH; Lee JM; Shin NY; Jung WH; Choi JS; Jang DP; Kwon JS
Schizophr Res; 2009 Jun; 111(1-3):86-93. PubMed ID: 19406622
[TBL] [Abstract][Full Text] [Related]
15. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.
Ohrmann P; Siegmund A; Suslow T; Pedersen A; Spitzberg K; Kersting A; Rothermundt M; Arolt V; Heindel W; Pfleiderer B
J Psychiatr Res; 2007 Oct; 41(8):625-34. PubMed ID: 16949099
[TBL] [Abstract][Full Text] [Related]
16. Detection of metabolites in the white matter of frontal lobes and hippocampus with proton in first-episode treatment-naïve schizophrenia patients.
He ZL; Deng W; Li ML; Chen ZF; Collier DA; Ma X; Li T
Early Interv Psychiatry; 2012 May; 6(2):166-75. PubMed ID: 21951785
[TBL] [Abstract][Full Text] [Related]
17. (1)H-magnetic resonance spectroscopy ((1)H-MRS) in methamphetamine dependence and methamphetamine induced psychosis.
Howells FM; Uhlmann A; Temmingh H; Sinclair H; Meintjes E; Wilson D; Stein DJ
Schizophr Res; 2014 Mar; 153(1-3):122-8. PubMed ID: 24529366
[TBL] [Abstract][Full Text] [Related]
18. Proton MRS in twin pairs discordant for schizophrenia.
Lutkenhoff ES; van Erp TG; Thomas MA; Therman S; Manninen M; Huttunen MO; Kaprio J; Lönnqvist J; O'Neill J; Cannon TD
Mol Psychiatry; 2010 Mar; 15(3):308-18. PubMed ID: 18645571
[TBL] [Abstract][Full Text] [Related]
19. Brain Glutamate, GABA, and Glutamine Levels and Associations with Recent Drinking in Treatment-Naïve Individuals with Alcohol Use Disorder Versus Light Drinkers.
Prisciandaro JJ; Schacht JP; Prescot AP; Renshaw PF; Brown TR; Anton RF
Alcohol Clin Exp Res; 2019 Feb; 43(2):221-226. PubMed ID: 30537347
[TBL] [Abstract][Full Text] [Related]
20. GABA and glutamate in schizophrenia: a 7 T ¹H-MRS study.
Marsman A; Mandl RC; Klomp DW; Bohlken MM; Boer VO; Andreychenko A; Cahn W; Kahn RS; Luijten PR; Hulshoff Pol HE
Neuroimage Clin; 2014; 6():398-407. PubMed ID: 25379453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
